CLEC9a Antibody (14N8D7) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-27087JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Primate, Rhesus Macaque
Applications
Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # 14N8D7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CLEC9a Antibody (14N8D7) [Janelia Fluor® 669]
Immunogen
A portion of amino acids 50-130 of human CLEC9A was used as the immunogen for the antibody.
Reactivity Notes
Orangutan, Chimp (100%), Canine, Panda, Equine (73%), Bovine (73%), Mouse (60%).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for CLEC9a Antibody (14N8D7) [Janelia Fluor® 669]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CLEC9a
Long Name
C-type Lectin-like Receptor 9
Alternate Names
CD370, DNGR1
Gene Symbol
CLEC9A
Additional CLEC9a Products
Product Documents for CLEC9a Antibody (14N8D7) [Janelia Fluor® 669]
Product Specific Notices for CLEC9a Antibody (14N8D7) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...